Showing results (1431-1440 of 4,166) with videos related to

Sort By:
Pageof 417
Translational Cancer Research|February 4, 2022
Establishment of a stable hepatic metastasis mouse model of murine colorectal cancer by microsurgical orthotopic implantationZhiyun Cao, Zhideng Zhang, Liangpu Zheng, et al.
Translational Cancer Research|February 4, 2022
ET-1 promotes the growth and metastasis of esophageal squamous cell carcinoma via activating PI3K/Akt pathwayHui Yin, Lunqing Wang, Fei Li, et al.
Translational Cancer Research|February 4, 2022
Pyruvate kinase M2 is a marker of poor prognosis in lung adenocarcinoma but not lung squamous cell carcinomaJunxia Zhang, Chengjuan Zhang, Xianghua Liu, et al.
Translational Cancer Research|February 4, 2022
Circular RNA circZFR promotes tumorigenic capacity of lung cancer via CCND1Guanjun Ren, Qiuhong Zhao, Chunliang Yan, et al.
Translational Cancer Research|February 4, 2022
Primary tumor resection and lymph node dissection improve survival in de novo metastatic pancreatic ductal adenocarcinoma: an inverse probability of treatment weighting analysisChaorui Wu, Xiaojie Zhang, Tongbo Wang, et al.
Translational Cancer Research|February 4, 2022
Claudin 18.2 expression in various tumor types and its role as a potential target in advanced gastric cancerJung Yong Hong, Ji Yeong An, Jeeyun Lee, et al.
Translational Cancer Research|February 4, 2022
Different primers for diagnosing circulating cell-free DNA of colorectal cancerHao Shi, Qigang Li, Juan Liao, et al.
Translational Cancer Research|February 4, 2022
A prognostic nomogram for pancreatic ductal adenocarcinoma patients' all-cause survival in a Surveillance, Epidemiology, and End Results analysisChengzhuo Li, Zhenhu Ren, Didi Han, et al.
Translational Cancer Research|February 4, 2022
Elevated expression of mitochondrial transcription elongation factor (TEFM) predicts poor prognosis in low grade glioma-an analysis of the Cancer Genome Atlas (TCGA) datasetSufen Li, Weisi Wang, Jiaji Zi, et al.
Translational Cancer Research|February 4, 2022
The efficacy of afatinib in patients with HER2 mutant non-small cell lung cancer: a meta-analysisNiya Zhou, Jie Zhao, Xiu Huang, et al.
Pageof 417